SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)

Esophageal cancer is an aggressive tumor, and is the sixth-leading cause of death from cancer. Incidence is rising in Spain, particularly among men. Two main pathological different subtypes have been described: squamous cell carcinoma and adenocarcinoma. Growing evidence of their epidemiology and mo...

ver descrição completa

Detalhes bibliográficos
Autores: Fernandez-Montes, A, Alcaide, J, Alsina, M, Custodio, AB, Franco, LF, Plazas, JG, Gomez-Martin, C, Richart, P, Rivera, F, Martin-Richard, M
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Recursos:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p13480
Acesso em linha:https://fisabio.portalinvestigacion.com/publicaciones/13480
Access Level:acceso abierto
Palavra-chave:Esophageal cancer
Diagnosis
Treatment
id ES_43453941c41b939ea3feb8e4c9dba98f
oai_identifier_str oai:fisabio.fundanetsuite.com:p13480
network_acronym_str ES
network_name_str España
repository_id_str
spelling SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)Fernandez-Montes, AAlcaide, JAlsina, MCustodio, ABFranco, LFPlazas, JGGomez-Martin, CRichart, PRivera, FMartin-Richard, MEsophageal cancerDiagnosisTreatmentEsophageal cancer is an aggressive tumor, and is the sixth-leading cause of death from cancer. Incidence is rising in Spain, particularly among men. Two main pathological different subtypes have been described: squamous cell carcinoma and adenocarcinoma. Growing evidence of their epidemiology and molecular differences explains their different response to novel treatments, and they are therefore likely to be treated as two separate entities in the near future. The best results are obtained with a multidisciplinary therapeutic strategy, and the introduction of immunotherapy is a promising new approach that will improve prognosis. In these guidelines, we review the evidence for the different methods of diagnosis and therapeutic strategies that form the basis of our standard of care.SPRINGER INT PUBL AG2022info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/13480Clinical & Translational OncologyISSN: 1699048XISSNe: 16993055reponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Inglésinfo:eu-repo/semantics/openAccessoai:fisabio.fundanetsuite.com:p134802026-06-11T12:45:17Z
dc.title.none.fl_str_mv SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)
title SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)
spellingShingle SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)
Fernandez-Montes, A
Esophageal cancer
Diagnosis
Treatment
title_short SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)
title_full SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)
title_fullStr SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)
title_full_unstemmed SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)
title_sort SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)
dc.creator.none.fl_str_mv Fernandez-Montes, A
Alcaide, J
Alsina, M
Custodio, AB
Franco, LF
Plazas, JG
Gomez-Martin, C
Richart, P
Rivera, F
Martin-Richard, M
author Fernandez-Montes, A
author_facet Fernandez-Montes, A
Alcaide, J
Alsina, M
Custodio, AB
Franco, LF
Plazas, JG
Gomez-Martin, C
Richart, P
Rivera, F
Martin-Richard, M
author_role author
author2 Alcaide, J
Alsina, M
Custodio, AB
Franco, LF
Plazas, JG
Gomez-Martin, C
Richart, P
Rivera, F
Martin-Richard, M
author2_role author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Esophageal cancer
Diagnosis
Treatment
topic Esophageal cancer
Diagnosis
Treatment
description Esophageal cancer is an aggressive tumor, and is the sixth-leading cause of death from cancer. Incidence is rising in Spain, particularly among men. Two main pathological different subtypes have been described: squamous cell carcinoma and adenocarcinoma. Growing evidence of their epidemiology and molecular differences explains their different response to novel treatments, and they are therefore likely to be treated as two separate entities in the near future. The best results are obtained with a multidisciplinary therapeutic strategy, and the introduction of immunotherapy is a promising new approach that will improve prognosis. In these guidelines, we review the evidence for the different methods of diagnosis and therapeutic strategies that form the basis of our standard of care.
publishDate 2022
dc.date.none.fl_str_mv 2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fisabio.portalinvestigacion.com/publicaciones/13480
url https://fisabio.portalinvestigacion.com/publicaciones/13480
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv SPRINGER INT PUBL AG
publisher.none.fl_str_mv SPRINGER INT PUBL AG
dc.source.none.fl_str_mv Clinical & Translational Oncology
ISSN: 1699048X
ISSNe: 16993055
reponame:r-FISABIO. Repositorio Institucional de Producción Científica
instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
collection r-FISABIO. Repositorio Institucional de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869407012105748480
score 15,812429

Registos relacionados